| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 06/15/2005 | CN1206359C High efficiency retroviral vector which contains genetically engineered cellular non-coding sequence harboring splicing acceptor |
| 06/15/2005 | CN1206356C Breeding of hepatitis A virus Chinese strain and attenuated strain and its complementary DNA sequence |
| 06/15/2005 | CN1206355C HIV vaccine |
| 06/14/2005 | US6906181 Antibody; for use in the detection and modulation of stress and aging defects |
| 06/14/2005 | US6906172 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 06/14/2005 | US6905862 Method for producing recombinant adenovirus |
| 06/14/2005 | US6905678 Gene delivery vectors with cell type specificity for mesenchymal stem cells |
| 06/09/2005 | WO2005052116A2 Preservative-containing virus formulations |
| 06/09/2005 | WO2005051433A1 Method for treating human tumor cells with a newcastle disease virus strain and a chemotherapeutic agent |
| 06/09/2005 | WO2005051330A2 METHOD FOR TREATING HUMAN TUMOR CELLS WITH A NEWCASTLE DISEASE VIRUS STRAIN HAVING A p53 INDEPENDENT ONCOLYTIC EFFECT |
| 06/09/2005 | WO2005028658A3 Recombinant influenza vectors with a polii promoter and ribozymes |
| 06/09/2005 | WO2005019470A3 Detecting and profiling molecular complexes |
| 06/09/2005 | WO2005001103A3 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 06/09/2005 | WO2003062400A9 Fiber shaft modifications for efficient targeting |
| 06/09/2005 | US20050124573 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 06/09/2005 | US20050124070 VAC-BAC shuttle vector system |
| 06/09/2005 | US20050124068 Hepatocellular carcinoma specific promoter and uses thereof |
| 06/09/2005 | US20050123898 Viral propagation mixture comprising expression vector, packaging cell line and donor plasmid for use in insertion, amplification, propagation and expression of heterologous gene sequences |
| 06/09/2005 | US20050123564 Production of viruses viral isolates and vaccines |
| 06/09/2005 | US20050123555 Alphavirus vectors and virosomes with modified HIV genes for use as vaccines |
| 06/09/2005 | US20050123515 retroviral vectors comprising nucleotide sequences that code envelope proteins, capable of transduction to target site |
| 06/09/2005 | US20050123513 Use of a reovirus for the manufacture of a medicament for treating a Ras-mediated neoplasm; administering reovirus to a Ras-mediated neoplasm without the side effects associated with other forms of cancer therapy; anticancer |
| 06/09/2005 | DE10144664B4 Vacciniavirus MVA-E3L-Knock-Out-Mutanten und Verwendung hiervon Vaccinia virus MVA-E3L knock-out mutants and use thereof |
| 06/08/2005 | EP1538209A2 Self-assembling recombinant hpv16 papillomavirus capsid proteins |
| 06/08/2005 | EP1537872A1 Immunostimulator having antineoplastic action and method for producing said immunostimulator |
| 06/08/2005 | EP1537206A2 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 06/08/2005 | EP1537205A2 Viral deconstruction through capsid assembly in vitro |
| 06/08/2005 | CN1625598A Methods to culture circovirus |
| 06/08/2005 | CN1624144A Process for high efficient fast concentriting adeno associated virus vector |
| 06/08/2005 | CN1624141A Process for raising expressing content of colyliform virus VPT or VP4 in plant and its product |
| 06/08/2005 | CN1624135A DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence programmed and cell death in plants |
| 06/08/2005 | CN1624117A Process for structuring combined rhabdovirus by high-flux clone |
| 06/08/2005 | CN1624116A Artificial recombined influenza virus and its application |
| 06/02/2005 | WO2005049845A2 Oncolytic herpes simplex virus encoding a heterologous nitroreductase |
| 06/02/2005 | WO2005049844A2 Vectors, mutant viruses and methods for generating mutant viruses |
| 06/02/2005 | WO2005049825A1 Method of detecting signal transduction by g protein-coupled receptor using germination baculovirus |
| 06/02/2005 | WO2005049815A1 Flavivirus replication |
| 06/02/2005 | WO2005049814A2 Novel atypical pneumonia-causing virus |
| 06/02/2005 | WO2005049813A1 Isolated phages and their use as disinfectant in food or for sanitation of factory environment |
| 06/02/2005 | WO2005049794A2 Methods of characterizing infectious bursal disease virus |
| 06/02/2005 | WO2005049639A2 Compositions and methods for protein isolation |
| 06/02/2005 | WO2005049077A2 Avian vaccine effective against infectious bursal disease virus |
| 06/02/2005 | WO2005025497A3 Hpv cd8+ t-cell epitopes |
| 06/02/2005 | WO2005014836A3 Chimaeric vector system |
| 06/02/2005 | WO2005005637A3 Herpes simplex virus comprising a genetically modified glycoprotein d |
| 06/02/2005 | WO2004074507A8 Method to confer cell culture replication activity to different hepatitis c virus isolates |
| 06/02/2005 | WO2004066947B1 Hyperthermia oncolysis co-therapy |
| 06/02/2005 | US20050119472 GB virus C and methods of treating viral infections |
| 06/02/2005 | US20050119471 RNA viral sequences for use in development of vaccine to prevent gastrointestinal disorders in infants and young children |
| 06/02/2005 | US20050119455 Polypeptide fusion comprising complementary determining regions for use as tool in immunotherapeutic and/or diagnostics; bioassay |
| 06/02/2005 | US20050118701 Large scale methods of producing adenovirus and adenovirus seed stocks |
| 06/02/2005 | US20050118700 Immortalized avian cell lines |
| 06/02/2005 | US20050118698 Propagating viral particle in BHK (baby hamster kidney) and MDCK (mandine darby canine kidney) cell lines; for use as bioreactor for producing drugs and/or diagnostic agents |
| 06/02/2005 | US20050118571 Nucleic acids comprising viral genome and ribozyme sequences for use in animal models system for designing treatments for prevention of hepatitis viral infection |
| 06/02/2005 | US20050118567 Method for determining sensitivity to a bacteriophage |
| 06/02/2005 | US20050118566 Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins |
| 06/02/2005 | US20050118251 Novel DNA-based vaccine against the encephalitis alphaviruses |
| 06/02/2005 | US20050118195 Virus causing respiratory tract illness in susceptible mammals |
| 06/02/2005 | US20050118192 Viral preparations, vectors, immunogens, and vaccines |
| 06/02/2005 | US20050118191 Optimization of gene sequences of chimeric virus-like particles for expression in insect cells |
| 06/02/2005 | US20050118161 Hevein-binding monoclonal antibodies |
| 06/02/2005 | US20050118140 Madin Darby Canine Kidney cells are virally infected and cultured in suspension on an industrial scale to produce the active ingredient, and then mixed with a carrier or dilluent |
| 06/02/2005 | DE10163098B4 Verfahren zur Hemmung der Replikation von Viren A method of inhibiting the replication of viruses |
| 06/02/2005 | CA2546355A1 Novel atypical pneumonia-causing virus |
| 06/02/2005 | CA2545886A1 Methods of characterizing infectious bursal disease virus |
| 06/01/2005 | EP1535995A1 Polynucleotides encoding the antigenic HIV type C env polypeptide and uses thereof |
| 06/01/2005 | EP1535993A1 Biomolecule transfer method using virus envelope and composition and system therefor |
| 06/01/2005 | EP1535927A1 Hbv precore protein capable of forming particles |
| 06/01/2005 | EP1534847A1 Retroviral vector and stable packaging cell lines |
| 06/01/2005 | EP1534846A1 Replicons of pestiviruses that do not express c and or e1 protein and infectious viral particles containing same, that can be used in vaccines |
| 06/01/2005 | EP1534344A2 Viruses and virus-like particles for multiple antigen and target display |
| 06/01/2005 | CN1621089A Method for removing endotoxin from influenza vaccine formulation |
| 06/01/2005 | CN1621088A Method for removing endotoxin from influenza vaccine formulation |
| 06/01/2005 | CN1204265C Method of concentrating and recovering a viral enzyme activity from biological samples |
| 06/01/2005 | CN1204247C Recombined adenovirus and its use in curing myocardial ischemia |
| 05/31/2005 | US6900368 Tomato antisense deoxyhypusine synthase molecule and method of inhibiting deoxyhypusine synthase expression in plants |
| 05/31/2005 | US6900049 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 05/31/2005 | US6900010 Taking a culture of recombinant cells comprises a reporter sequence; contacting cell culture with a sample containing HIV; adding a tester agent to the cell culture; and detecting change in a level of expression of reporter gene in culture |
| 05/31/2005 | US6899884 Vaccine against mumps containing a jeryl-lynn virus strain |
| 05/31/2005 | US6899871 Gene delivery system and methods of use |
| 05/26/2005 | WO2005047481A2 Novel sequences encoding hapatitis c virus glycoproteins |
| 05/26/2005 | WO2005047458A2 Modified recombinant vaccina viruses and other microorganisms, uses thereof |
| 05/26/2005 | WO2005010173A3 Keratinocyte culturing method and the use thereof |
| 05/26/2005 | WO2004027028A3 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture |
| 05/26/2005 | US20050112765 Genetic engineering polypeptides containing capsids; cell transduction |
| 05/26/2005 | US20050112752 Method for the purification of alphavirus replicon particles |
| 05/26/2005 | US20050112556 Drug screening; endogenous human retrovirus; protein or peptide expressed by said retrovirus |
| 05/26/2005 | US20050112554 An insertion/a deletion early-stage-specific molecular marker, a single nucleotide variation (SNV) early-stage-specific molecular marker; SARS-CoV (coronaviruses) strains obtained from the earliest infected patients in a SARS outbreak, uses of these data for diagnosis, drug/vaccine development |
| 05/26/2005 | US20050112144 Deactivated, cell-free; culture product using protease; harvesting; separation |
| 05/26/2005 | US20050112143 Method of developing an immunogenic composition and HIV vaccine |
| 05/26/2005 | US20050112142 Methods and compositions for treatment and prevention of HSV-2 infections and conditions |
| 05/26/2005 | US20050112140 Immunogenic composition and method of developing a vaccine based on portions of the HIV matrix protein |
| 05/26/2005 | US20050112139 Immunogenic composition and method of developing a vaccine based on factor H binding sites |
| 05/26/2005 | US20050112103 Genetic engineered vectors encoding human low density lipoproteins ; control sequencing, gene expressionin heptacytes; anticholesterol agents; antilipemic agents |
| 05/26/2005 | CA2545938A1 High-titer retroviral packaging cells |
| 05/26/2005 | CA2544253A1 Novel sequences encoding hepatitis c virus glycoproteins |
| 05/26/2005 | CA2541941A1 Anti-bacterial phage tail compositions and uses thereof |
| 05/25/2005 | EP1533381A1 Adenovirus vector |
| 05/25/2005 | EP1533370A1 Novel atypical pneumonia-causing virus |
| 05/25/2005 | EP1533369A1 Isolated phages and their use as disinfectant in food or for sanitation of factory environment |